Next-generation biomonitoring of the early-life chemical exposome in neonatal and infant development

Nat Commun. 2022 May 12;13(1):2653. doi: 10.1038/s41467-022-30204-y.

Abstract

Exposure to synthetic and natural chemicals is a major environmental risk factor in the etiology of many chronic diseases. Investigating complex co-exposures is necessary for a holistic assessment in exposome-wide association studies. In this work, a sensitive liquid chromatography-tandem mass spectrometry approach was developed and validated. The assay enables the analysis of more than 80 highly-diverse xenobiotics in urine, serum/plasma, and breast milk; with detection limits generally in the pg-ng mL-1 range. In plasma of extremely-premature infants, 27 xenobiotics are identified; including contamination with plasticizers, perfluorinated alkylated substances and parabens. In breast milk samples collected longitudinally over the first 211 days post-partum, 29 analytes are detected, including pyrrolizidine- and tropane alkaloids which have not been identified in this matrix before. A preliminary estimation of daily toxicant intake via breast milk is conducted. In conclusion, we observe significant early-life co-exposure to multiple toxicants, and demonstrate the method's applicability for large-scale exposomics-type cohort studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Monitoring
  • Child
  • Child Development
  • Exposome*
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Tandem Mass Spectrometry / methods
  • Xenobiotics / toxicity

Substances

  • Xenobiotics